The excerpt discusses a study comparing the measurement of prostate volume (PV) using different methods and guidelines. The study included 114 patients, and PV was measured by two observers following the recommendations of PI-RADS v2 and PI-RADS v2.1. The results showed excellent interobserver and intraobserver agreement for both guidelines, with slightly higher agreement observed for PI-RADS v2.1. The midsagittal plane measurements, as suggested by PI-RADS v2.1, provided more consistently reproducible results, likely due to the shape characteristics of the prostate gland. The study concluded that PV measurement using the ellipsoid formula is reliable, and PI-RADS v2.1 guidelines offer more consistently reproducible results for height measurements. Accurate PV assessment is crucial in the diagnosis and treatment of prostate diseases, and standardization of measurement methods and techniques is essential for reliable reporting. PV measurement is important in the diagnosis and treatment of both benign and malignant prostate diseases. Accurate assessment of PV helps in the evaluation of disease progression, treatment planning, and monitoring treatment response. Consistent and reliable PV measurements, as provided by guidelines such as PI-RADS v2.1, aid in standardizing reporting and improve communication among healthcare professionals, leading to better patient care and outcomes.